Published in Ann Thorac Surg on July 25, 2012
Comparative effectiveness of surgery and radiosurgery for stage I non-small cell lung cancer. Cancer (2015) 1.00
Update in lung cancer and mesothelioma 2012. Am J Respir Crit Care Med (2013) 0.87
Surveillance Practice Patterns after Curative Intent Therapy for Stage I Non-Small-Cell Lung Cancer in the Medicare Population. Lung Cancer (2016) 0.75
Comorbidity measures for use with administrative data. Med Care (1998) 46.67
Hospital volume and surgical mortality in the United States. N Engl J Med (2002) 25.79
Racial differences in the treatment of early-stage lung cancer. N Engl J Med (1999) 9.65
Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg (1995) 9.51
Data from The Society of Thoracic Surgeons General Thoracic Surgery database: the surgical management of primary lung tumors. J Thorac Cardiovasc Surg (2007) 4.15
Patient demographic and socioeconomic characteristics in the SEER-Medicare database applications and limitations. Med Care (2002) 3.57
Factors associated with decisions to undergo surgery among patients with newly diagnosed early-stage lung cancer. JAMA (2010) 2.99
Racial differences in trust and lung cancer patients' perceptions of physician communication. J Clin Oncol (2006) 2.67
Racial disparities in cancer therapy: did the gap narrow between 1992 and 2002? Cancer (2008) 2.60
Treatment of non-small cell lung cancer stage I and stage II: ACCP evidence-based clinical practice guidelines (2nd edition). Chest (2007) 2.60
Patterns of surgical care of lung cancer patients. Ann Thorac Surg (2005) 2.51
Limited resection for the treatment of patients with stage IA lung cancer. Ann Surg (2010) 2.35
Survival following lobectomy and limited resection for the treatment of stage I non-small cell lung cancer<=1 cm in size: a review of SEER data. Chest (2010) 2.26
Outcomes of sublobar resection versus lobectomy for stage I non-small cell lung cancer: a 13-year analysis. Ann Thorac Surg (2006) 2.12
Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: ACCP evidenced-based clinical practice guidelines (2nd edition). Chest (2007) 1.99
Factors predicting poor survival after resection of stage IA non-small cell lung cancer. J Thorac Cardiovasc Surg (2007) 1.66
Sublobar resection provides an equivalent survival after lobectomy in elderly patients with early lung cancer. Ann Thorac Surg (2010) 1.62
Impact of hospital volume of thoracoscopic lobectomy on primary lung cancer outcomes. Ann Thorac Surg (2011) 1.59
Surgical treatment of lung cancer in the octogenarians: results of a nationwide audit. Eur J Cardiothorac Surg (2010) 1.51
Sublobar resection for early-stage lung cancer. Semin Thorac Cardiovasc Surg (2010) 1.11
The relationship between hospital lung cancer resection volume and patient mortality risk. Ann Surg (2011) 1.05
A decade of mortality reductions in major oncologic surgery: the impact of centralization and quality improvement. Med Care (2010) 1.04
Disparities in surgical resection of early-stage non-small cell lung cancer. J Thorac Cardiovasc Surg (2002) 0.97
Predictors and outcomes of limited resection for early-stage non-small cell lung cancer. J Natl Cancer Inst (2011) 0.96
Risk assessment for pulmonary resection. Semin Thorac Cardiovasc Surg (2010) 0.82
Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA (2003) 16.08
Participation in cancer clinical trials: race-, sex-, and age-based disparities. JAMA (2004) 14.05
Benefits and harms of CT screening for lung cancer: a systematic review. JAMA (2012) 8.71
Are racial and ethnic minorities less willing to participate in health research? PLoS Med (2005) 7.88
Stereotactic body radiation therapy versus intensity-modulated radiation therapy for prostate cancer: comparison of toxicity. J Clin Oncol (2014) 6.62
The new lung cancer staging system. Chest (2009) 6.30
Postoperative radiotherapy for stage II or III non-small-cell lung cancer using the surveillance, epidemiology, and end results database. J Clin Oncol (2006) 5.09
Representation of the elderly, women, and minorities in heart failure clinical trials. Arch Intern Med (2002) 4.45
Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study. J Clin Oncol (2011) 4.07
Proton versus intensity-modulated radiotherapy for prostate cancer: patterns of care and early toxicity. J Natl Cancer Inst (2012) 3.72
Clinical practice. Superior vena cava syndrome with malignant causes. N Engl J Med (2007) 3.39
Patterns of use and short-term complications of breast brachytherapy in the national medicare population from 2008-2009. J Clin Oncol (2012) 3.34
Most hospitalized older persons do not meet the enrollment criteria for clinical trials in heart failure. Am Heart J (2003) 3.11
Assessing the impact of a cooperative group trial on breast cancer care in the medicare population. J Clin Oncol (2012) 3.07
Pharmaceutical company payments to physicians: early experiences with disclosure laws in Vermont and Minnesota. JAMA (2007) 3.03
Recruiting vulnerable populations into research: a systematic review of recruitment interventions. J Gen Intern Med (2007) 3.02
Hospital and surgeon procedure volume as predictors of outcome following rectal cancer resection. Ann Surg (2002) 2.71
Effectiveness of radiation therapy for older women with early breast cancer. J Natl Cancer Inst (2006) 2.69
Integrated prostate cancer centers and over-utilization of IMRT: a close look at fee-for-service medicine in radiation oncology. Int J Radiat Oncol Biol Phys (2010) 2.66
The relationship between clinical benefit and receipt of curative therapy for prostate cancer. Arch Intern Med (2012) 2.48
Participation in surgical oncology clinical trials: gender-, race/ethnicity-, and age-based disparities. Ann Surg Oncol (2007) 2.46
Effect of blinded peer review on abstract acceptance. JAMA (2006) 2.38
The association between diffusion of the surgical robot and radical prostatectomy rates. Med Care (2011) 2.38
Sharing of clinical trial data among trialists: a cross sectional survey. BMJ (2012) 2.31
Patients' views on financial conflicts of interest in cancer research trials. N Engl J Med (2006) 2.29
Incidence of heart failure or cardiomyopathy after adjuvant trastuzumab therapy for breast cancer. J Am Coll Cardiol (2012) 2.18
The importance of clinical trial data sharing: toward more open science. Circ Cardiovasc Qual Outcomes (2012) 2.16
Variation in treatment recommendations of adjuvant radiation therapy for high-risk prostate cancer by physician specialty. Urology (2013) 2.16
Perceptions of Active Surveillance and Treatment Recommendations for Low-risk Prostate Cancer: Results from a National Survey of Radiation Oncologists and Urologists. Med Care (2014) 2.14
NCI SEER public-use data: applications and limitations in oncology research. Oncology (Williston Park) (2009) 2.01
Should the 7th edition of the lung cancer stage classification system change treatment algorithms in non-small cell lung cancer? J Thorac Oncol (2010) 2.00
Outcomes for lung transplantation for lung cancer in the United Network for Organ Sharing Registry. Ann Thorac Surg (2012) 1.99
Anesthesiologist involvement in screening colonoscopy: temporal trends and cost implications in the medicare population. Clin Gastroenterol Hepatol (2011) 1.97
Surveillance, Epidemiology, and End Results (SEER) database analysis of microcystic adnexal carcinoma (sclerosing sweat duct carcinoma) of the skin. Am J Clin Oncol (2010) 1.96
Surveillance epidemiology and end results evaluation of the role of surgery for stage I small cell lung cancer. J Thorac Oncol (2010) 1.94
Use of hospital-based acute care among patients recently discharged from the hospital. JAMA (2013) 1.88
Incorporating bevacizumab and erlotinib in the combined-modality treatment of stage III non-small-cell lung cancer: results of a phase I/II trial. J Clin Oncol (2012) 1.84
Physician violations of online professionalism and disciplinary actions: a national survey of state medical boards. JAMA (2012) 1.81
Assessing the impact of screening colonoscopy on mortality in the medicare population. J Gen Intern Med (2011) 1.73
Validation of the partin nomogram for prostate cancer in a national sample. J Urol (2010) 1.64
Regional variation in total cost per radical prostatectomy in the healthcare cost and utilization project nationwide inpatient sample database. J Urol (2010) 1.64
Laparoscopic colectomy for the treatment of cancer has been widely adopted in the United States. Dis Colon Rectum (2012) 1.62
Counterpoint: are limited resections appropriate in non-small cell lung cancer? No: don't overdo it, and don't get confused. Chest (2012) 1.60
Mohs micrographic surgery and surgical excision for nonmelanoma skin cancer treatment in the Medicare population. Arch Dermatol (2012) 1.60
The impact of pretreatment prostate volume on severe acute genitourinary toxicity in prostate cancer patients treated with intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys (2010) 1.59
Impact of hospital volume of thoracoscopic lobectomy on primary lung cancer outcomes. Ann Thorac Surg (2011) 1.59
Comorbidities and survival in a large cohort of patients with newly diagnosed myelodysplastic syndromes. Leuk Res (2009) 1.57
Induction and concurrent chemotherapy with high-dose thoracic conformal radiation therapy in unresectable stage IIIA and IIIB non-small-cell lung cancer: a dose-escalation phase I trial. J Clin Oncol (2004) 1.56
Helical computed tomography inaccuracy in the detection of pulmonary metastases: can it be improved? Ann Thorac Surg (2007) 1.54
Geographical information systems: applications and limitations in oncology research. Oncology (Williston Park) (2011) 1.52
Validity of a simple ST-elevation acute myocardial infarction risk index: are randomized trial prognostic estimates generalizable to elderly patients? Circulation (2003) 1.50
Understanding regional variation in Medicare expenditures for initial episodes of prostate cancer care. Med Care (2014) 1.50
A randomized outpatient trial of a decision-support information technology tool. Arch Intern Med (2005) 1.49
Surgery versus implant for early prostate cancer: results from a single institution, 1992-2005. Cancer J (2007) 1.46
Promoting transparency in pharmaceutical industry-sponsored research. Am J Public Health (2011) 1.46
A historic moment for open science: the Yale University Open Data Access project and medtronic. Ann Intern Med (2013) 1.45
Effectiveness of radiation therapy in older women with ductal carcinoma in situ. J Natl Cancer Inst (2006) 1.44
Hospital-level outcomes associated with laparoscopic colectomy for cancer in the minimally invasive era. J Gastrointest Surg (2012) 1.43
Standard outcome measures for thymic malignancies. J Thorac Oncol (2010) 1.39
Ultrasensitive measurement of hotspot mutations in tumor DNA in blood using error-suppressed multiplexed deep sequencing. Cancer Res (2012) 1.39
Systematic review evaluating the timing of thoracic radiation therapy in combined modality therapy for limited-stage small-cell lung cancer. J Clin Oncol (2004) 1.37
Involuntary job loss as a risk factor for subsequent myocardial infarction and stroke: findings from the Health and Retirement Survey. Am J Ind Med (2004) 1.31
Impact of comorbidity on mortality among older persons with advanced heart failure. J Gen Intern Med (2011) 1.31
The shortage of on-call surgical specialist coverage: a national survey of emergency department directors. Acad Emerg Med (2010) 1.27
Immortal time bias: a frequently unrecognized threat to validity in the evaluation of postoperative radiotherapy. Int J Radiat Oncol Biol Phys (2012) 1.25
Adoption of spironolactone therapy for older patients with heart failure and left ventricular systolic dysfunction in the United States, 1998-2001. Circulation (2005) 1.24
Polypharmacy in older adults with cancer. Oncologist (2010) 1.23
The impact of thymoma histotype on prognosis in a worldwide database. J Thorac Oncol (2015) 1.20
Stereotactic body radiotherapy for central lung tumors. J Thorac Oncol (2012) 1.18
Online professionalism investigations by state medical boards: first, do no harm. Ann Intern Med (2013) 1.18
Estimating the magnitude of colorectal cancers prevented during the era of screening: 1976 to 2009. Cancer (2014) 1.18
Determinants and patterns of survival in adenoid cystic carcinoma of the head and neck, including an analysis of adjuvant radiation therapy. Am J Clin Oncol (2011) 1.16
Superior vena cava syndrome--a proposed classification system and algorithm for management. J Thorac Oncol (2008) 1.16
Standard terms, definitions, and policies for minimally invasive resection of thymoma. J Thorac Oncol (2011) 1.16
The population level prevalence and correlates of appropriate and inappropriate imaging to stage incident prostate cancer in the medicare population. J Urol (2011) 1.16
Contribution of individual diseases to death in older adults with multiple diseases. J Am Geriatr Soc (2012) 1.15
Physicians' ratings of their knowledge, attitudes, and end-of-life-care practices. Acad Med (2002) 1.15
Risk prediction model for heart failure and cardiomyopathy after adjuvant trastuzumab therapy for breast cancer. J Am Heart Assoc (2014) 1.14